| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment of NeuroAIDS in the International Setting
|
Robertson, Kevin R.
|
|
2007
|
2 |
1 |
p. 105-111
|
artikel
|
| 2 |
Biomarkers for NeuroAIDS: The Widening Scope of Metabolomics
|
Pendyala, Gurudutt
|
|
2006
|
2 |
1 |
p. 72-80
|
artikel
|
| 3 |
Biomarkers, Laboratory, and Animal Models for the Design and Development of Adjunctive Therapies for HIV-1 Dementia and other Neuroinflammatory Disorders
|
Gendelman, Howard E.
|
|
2007
|
2 |
1 |
p. 8-13
|
artikel
|
| 4 |
Clinical Trials in HIV CNS Disease and Treatment Management
|
Ellis, Ronald J.
|
|
2007
|
2 |
1 |
p. 20-25
|
artikel
|
| 5 |
Defining and Evaluating HIV-Related Neurodegenerative Disease and Its Treatment Targets: A Combinatorial Approach to Use of Cerebrospinal Fluid Molecular Biomarkers
|
Gisslen, Magnus
|
|
2006
|
2 |
1 |
p. 112-119
|
artikel
|
| 6 |
Facilitating Compound Progression of Antiretroviral Agents via Modeling and Simulation
|
Barrett, Jeffrey S.
|
|
2007
|
2 |
1 |
p. 58-71
|
artikel
|
| 7 |
Facilitating Compound Progression of Antiretroviral Agents via Modeling and Simulation
|
Barrett, Jeffrey S.
|
|
|
2 |
1 |
p. 58-71
|
artikel
|
| 8 |
Glycogen Synthase Kinase 3 Beta (GSK-3β) as a Therapeutic Target in NeuroAIDS
|
Dewhurst, Stephen
|
|
2006
|
2 |
1 |
p. 93-96
|
artikel
|
| 9 |
HIV Preclinical–Clinical Therapeutics Research: Central Nervous System Approaches
|
Kopnisky, Kathy L.
|
|
2007
|
2 |
1 |
p. 1-4
|
artikel
|
| 10 |
Intranasal Tat Alters Gene Expression in the Mouse Brain
|
Pulliam, Lynn
|
|
2007
|
2 |
1 |
p. 87-92
|
artikel
|
| 11 |
Meeting Practical Challenges of a Trial Involving a Multitude of Treatment Regimens: An Example of a Multi-Center Randomized Controlled Clinical Trial in NeuroAIDS
|
May, Susanne
|
|
2007
|
2 |
1 |
p. 97-104
|
artikel
|
| 12 |
Neurokinin-1 Receptor Antagonist (Aprepitant) Inhibits Drug-Resistant HIV-1 Infection of Macrophages in vitro
|
Wang, Xu
|
|
2007
|
2 |
1 |
p. 42-48
|
artikel
|
| 13 |
Neuroprotective and Antiretroviral Effects of the Immunophilin ligand GPI 1046
|
Steiner, Joseph P.
|
|
2007
|
2 |
1 |
p. 49-57
|
artikel
|
| 14 |
NIMH Preclinical/Clinical Therapeutics Research Meeting—Preclinical Drug Discovery Session
|
Douglas, Steven D.
|
|
2007
|
2 |
1 |
p. 5-7
|
artikel
|
| 15 |
Strategies for Intranasal Delivery of Therapeutics for the Prevention and Treatment of NeuroAIDS
|
Hanson, Leah R.
|
|
2006
|
2 |
1 |
p. 81-86
|
artikel
|
| 16 |
Studying Host–Pathogen Interactions in 3-D: Organotypic Models for Infectious Disease and Drug Development
|
Nickerson, Cheryl A.
|
|
2006
|
2 |
1 |
p. 26-31
|
artikel
|
| 17 |
The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System
|
Letendre, Scott L.
|
|
2007
|
2 |
1 |
p. 120-127
|
artikel
|
| 18 |
Translational Research Models and Novel Adjunctive Therapies for NeuroAIDS
|
Zink, M. Christine
|
|
2007
|
2 |
1 |
p. 14-19
|
artikel
|
| 19 |
Variation of Macrophage Tropism among HIV-1 R5 Envelopes in Brain and Other Tissues
|
Peters, Paul J.
|
|
2006
|
2 |
1 |
p. 32-41
|
artikel
|
Tijdschrift beschrijving